Compare GOOS & YDES Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | GOOS | YDES |
|---|---|---|
| Founded | 1957 | 2013 |
| Country | Canada | Taiwan |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 894.2M |
| IPO Year | 2016 | N/A |
| Metric | GOOS | YDES |
|---|---|---|
| Price | $10.99 | $7.80 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $12.60 | N/A |
| AVG Volume (30 Days) | ★ 506.8K | 12.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $12.21 | N/A |
| Revenue Next Year | $5.16 | N/A |
| P/E Ratio | $75.22 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.73 | $7.51 |
| 52 Week High | $15.43 | $25.00 |
| Indicator | GOOS | YDES |
|---|---|---|
| Relative Strength Index (RSI) | 36.57 | 31.53 |
| Support Level | $10.94 | N/A |
| Resistance Level | $14.45 | $9.46 |
| Average True Range (ATR) | 0.36 | 0.52 |
| MACD | -0.09 | 0.01 |
| Stochastic Oscillator | 13.91 | 12.31 |
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.
YD Bio Ltd is a biopharmaceutical company focusing on blood-based cancer detection, the development of stem cell- and exosome-based therapeutics with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need and serving as a trusted supplier of clinical testing drugs for pharmaceutical companies. Stem cell therapy uses versatile cells to repair or regenerate damaged tissues, offering innovative treatments for injuries, degenerative diseases, and immune disorders with potential for personalized medicine and tissue engineering.